Meeting
2016 ASCO Annual Meeting
Genetic variations in endometrial cancer by histology, stage and BMI.
Authors
Dario R. Roque
University of North Carolina, Chapel Hill, NC
Dario R. Roque , Tara Castellano , David N. Hayes , A. Mitch Dizon , Leslie Horn Clark , Stuart Pierce , Weiya Zhang Wysham , Rashid Naim , Paola A. Gehrig , Victoria Lin Bae-Jump
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 5593)
DOI
10.1200/JCO.2016.34.15_suppl.5593
Abstract #
5593
Poster Bd #
416
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
A 12 multigene NGS panel to characterize molecular biotypes in endometrial cancer.
First Author: Ignacio Romero
Poster
2023 ASCO Annual Meeting
The impact of cause of mismatch repair deficiency and other molecular markers on clinical outcomes with the use of durvalumab in advanced endometrial cancer in the phase 2 PHAEDRA trial (ANZGOG1601).
First Author: Daniel D. Buchanan
Poster
2015 Breast Cancer Symposium
Molecular profiling of triple-negative endometrial cancers (TNEC) and triple-negative breast cancers (TNBC) to reveal unique expression profiles.
First Author: Nathaniel L. Jones
Poster
2015 ASCO Annual Meeting
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
First Author: Andrea P. Myers